1. Home
  2. GBIO vs EXFY Comparison

GBIO vs EXFY Comparison

Compare GBIO & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • EXFY
  • Stock Information
  • Founded
  • GBIO 2016
  • EXFY 2008
  • Country
  • GBIO United States
  • EXFY United States
  • Employees
  • GBIO N/A
  • EXFY N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • EXFY Computer Software: Prepackaged Software
  • Sector
  • GBIO Health Care
  • EXFY Technology
  • Exchange
  • GBIO Nasdaq
  • EXFY Nasdaq
  • Market Cap
  • GBIO 29.5M
  • EXFY 165.4M
  • IPO Year
  • GBIO 2020
  • EXFY 2021
  • Fundamental
  • Price
  • GBIO $5.95
  • EXFY $1.92
  • Analyst Decision
  • GBIO Buy
  • EXFY Strong Buy
  • Analyst Count
  • GBIO 4
  • EXFY 3
  • Target Price
  • GBIO $10.67
  • EXFY $4.75
  • AVG Volume (30 Days)
  • GBIO 75.1K
  • EXFY 460.8K
  • Earning Date
  • GBIO 11-05-2025
  • EXFY 11-06-2025
  • Dividend Yield
  • GBIO N/A
  • EXFY N/A
  • EPS Growth
  • GBIO N/A
  • EXFY N/A
  • EPS
  • GBIO N/A
  • EXFY N/A
  • Revenue
  • GBIO $21,230,000.00
  • EXFY $144,251,000.00
  • Revenue This Year
  • GBIO N/A
  • EXFY $5.45
  • Revenue Next Year
  • GBIO N/A
  • EXFY $2.56
  • P/E Ratio
  • GBIO N/A
  • EXFY N/A
  • Revenue Growth
  • GBIO 61.15
  • EXFY 4.13
  • 52 Week Low
  • GBIO $3.00
  • EXFY $1.60
  • 52 Week High
  • GBIO $29.10
  • EXFY $4.13
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 52.30
  • EXFY 51.48
  • Support Level
  • GBIO N/A
  • EXFY N/A
  • Resistance Level
  • GBIO $6.25
  • EXFY $1.97
  • Average True Range (ATR)
  • GBIO 0.30
  • EXFY 0.07
  • MACD
  • GBIO -0.30
  • EXFY -0.06
  • Stochastic Oscillator
  • GBIO 91.82
  • EXFY 93.20

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.

Share on Social Networks: